Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria.
Nishimura JI, Ando K, Masuko M, Noji H, Ito Y, Mayer J, Griskevicius L, Bucher C, Müllershausen F, Gergely P, Rozenberg I, Schubart A, Chawla R, Rondeau JM, Roguska M, Splawski I, Keating MT, Johnson L, Danekula R, Bagger M, Watanabe Y, Haraldsson B, Kanakura Y.
Nishimura JI, et al. Among authors: mayer j.
Haematologica. 2022 Jun 1;107(6):1483-1488. doi: 10.3324/haematol.2020.265868.
Haematologica. 2022.
PMID: 35263983
Free PMC article.
No abstract available.